Last Price Today's Change   Day's Range   Trading Volume
1.27   -0.01 (0.78%)  1.26 - 1.29  539,000
Analyze this stock with MQ Trader system


Market Cap: 841 Million
NOSH: 662 Million
Avg Volume (4 weeks):772,840
4 Weeks Range:1.25 - 1.44
4 Weeks Price Volatility (%):
52 Weeks Range:1.25 - 3.43
52 Weeks Price Volatility (%):
Average Price Target: 3.47
Price Target Upside/Downside: +2.20
Stamp duty exempted for year 2018

Financial Highlight

Latest Quarter | Ann. Date 31-Mar-2018 [#1]  |  28-May-2018
Next QR | Est. Ann. Date: 30-Jun-2018  |  25-Aug-2018
T4Q P/E | EY: 19.23  |  5.20%
T4Q DY | Payout %: 2.82%  |  54.25%
T4Q NAPS | P/NAPS: 0.3119  |  4.07
T4Q NP Margin | ROE: 9.04%  |  21.17%


Date Subject
18-Jul-2018 M+ Online Technical Focus - 18 Jul 2018
18-Jul-2018 Daily Market Update - 18 Jul 2018 (KRONO, CCMDBIO)
10-Jul-2018 CCM Duopharma Biotech - Solidifying Its No 1 Position in the Local Pharma Sector
21-Jun-2018 Technical Analysis - CCM Duopharma Biotech
08-Jun-2018 Mplus Market Pulse - 8 Jun 2018
30-May-2018 CCM Duopharma Biotech Bhd - Demand Remains Strong
30-May-2018 Mplus Market Pulse - 30 May 2018
25-May-2018 Daily Technical Highlights – (CCMDBIO, INARI)
30-Apr-2018 年产1.07亿片Flavettes维他命C.马化学药业泡腾科技领先
29-Mar-2018 CCM Duopharma Biotech Bhd - Sustainable Earnings
21-Mar-2018 [转贴]阿笔谈股系列20-浅谈CCM Duopharma’可负担’药物
14-Mar-2018 M+ Online Technical Focus - 14 Mar 2018
14-Mar-2018 Daily Market Update - 14 Mar 2018 (CCMDBIO, TRIPLC)
28-Feb-2018 CCM Duopharma Biotech Bhd - Expect Growth Momentum to Continue
08-Feb-2018 CCMDBIO – A good defensive play in a volatile market; Potential downtrend reversal amid hammer pattern
08-Feb-2018 CCMDBIO – A good defensive play in a volatile market; Potential downtrend reversal amid hammer pattern
26-Dec-2017 Mplus Market Pulse - 26 Dec 2017
26-Dec-2017 PublicInvest Research Headlines - 26 Dec 2017
11-Dec-2017 PublicInvest Research Headlines - 11 Dec 2017
11-Dec-2017 Mplus Market Pulse - 11 Dec 2017

Business Background

CCM Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures and markets generic and over-the-counter pharmaceutical products. Its segment is engaged in manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines. The company's products include tablets, capsules, syrup, oral antibiotic, creams, hemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges and eye drop preparations.
Trade this stock with T+7 trading account. Find out more.

  4 people like this.
DkNY Thanks for sharing necro.
08/01/2018 10:02
Investeye Total disposed more than half these few days after purchased started from 2 yrs ago and accumulated along 2016 & 2017..
10/01/2018 10:02
jibbie wow..looks like big funds buying in
11/01/2018 17:25
DkNY Just now though that can breaking RM3.00
12/01/2018 11:44
necro RM counter....RM will strengthen till RM3.85 & best case scenario RM3.6
15/01/2018 11:42
DkNY No matter how, CCMDBIO will show us its power of raise in the nearer period. Cheers......
16/01/2018 11:01
AnonymousKLSE Good morning. Today, we feature a note on CCM Duopharma Biotech Berhad in our FundTech Radar– 23rd Jan 2018. The company is Malaysia’s largest generic pharmaceutical manufacturer by volume and the first pharmaceutical company awarded the Halal Pharmaceuticals certification.

Fundamental Stance
• sales and PAT improved in 9MFY17 by 48.9% and 68.6% respectively, thanks to the increased demand from the public health sector via tenders and supply of traded specialty products
• expects a capex of RM306m for the manufacturing strategy
• net gearing is a comfortable 0.06x.
• paid dividend consistently since FY02 but both div. yield and payout have declined
• The completion of the state-of-the-art plant under its Manufacturing Optimisation Strategy will enable it to increase its production capacity by 50%
• expansion in high value niche therapeutic products
• Permodalan Nasional Bhd (PNB) has recently turned into the largest shareholder
• Other institutional shareholders (EPF, Pacific Mutual Fund & KAF Investment Funds) recently increased their stakes
• currently trading at 19.4x 12-month trailing P/E (7.8% discount to its domestic peers P/E of 21.1x)

Technical Front
Uptrend with rising trading volume.
Resistances: 3.03/3.25/3.35
Supports: 2.62/2.36/2.18

The above information is extracted from CIMB Research Report. For the full research reports, outlook and disclaimers, please logon to your account on www.itradecimb.com.my and click on <Research> Tab under Malaysia.

This FundTech Radar report is intended for educational purposes only. It represents a preliminary assessment of the subject company, and does not represent initiation into CIMB's coverage universe. It does not carry investment ratings and CIMB does not commit to regular updates on an ongoing basis.

23rd Jan 2018
Disclaimers: This distribution is by CIMB Investment Bank Berhad (“CIMB”) in Malaysia only. The views are our own as of this date and subject to change. No further distribution is allowed without our prior written consent. CIMB, its related corporations, affiliates and business partners make no recommendation, offer or invitation to transact in any securities, futures contracts or other instruments. Please make your independent evaluation, consider your own investment objectives and financial situation and consult your own professional advisers before participating in any transaction.
23/01/2018 11:27
AnonymousKLSE Still undervalued according to CIMB
23/01/2018 11:28
alpacino Thank you @Anonymous.
23/01/2018 18:02
DkNY Personally see that this is a four Ringgit stock in bursa klse.
24/01/2018 14:51
DkNY What's going on to this share?
05/02/2018 15:52
jibbie sell off and take profit first
07/02/2018 00:53
necro come on...sell off.?....weak mind
15/02/2018 13:57
necro whats going on?....come on bacarat....weak mind,jgn banyak melancap,nti weak mind...
15/02/2018 13:58
trulyinvest Huat ahhhhh.... bonus 4 for 3..' n dividen 6sen
27/02/2018 19:48
alpacino Good results. Well done.
27/02/2018 22:04
FreedomStrike Where to see the bonus ratio?
27/02/2018 23:09
trulyinvest Hold 3 shares dapat bonus 4 shares
27/02/2018 23:22
jibbie sold off too early. damn..
28/02/2018 06:27
bjgdila123 TA tp 3.40
28/02/2018 13:43
KLCI King Not bad result
28/02/2018 15:52
DkNY Should gap up soon!
01/03/2018 11:29
kkteng70 keep growing .
01/03/2018 18:39
trulyinvest Someone keep pressing it from going up
14/03/2018 20:02
trulyinvest epf keep buying
27/04/2018 16:58
trulyinvest keep going
16/05/2018 10:31
trulyinvest go go go
16/05/2018 11:50
necro Result superb plus pending approval bonus 4 for 3 on 31/5/18...
21/05/2018 13:52
necro Higher high formation...pending bonus 4 for 3
25/05/2018 01:43
littlebro Is the current price safe for entry ?
01/06/2018 10:37
necro Yes...more upside on the card pre bonus
01/06/2018 12:37
Christine Chen If I bought at RM3.40. How much will the price be after ex-bonus 4:3?
10/06/2018 00:21
trulyinvest The px wil be based on market px one day b4 ex bonus not your purchase px.
10/06/2018 08:56
Christine Chen Thank you, trulyinvest.
10/06/2018 17:05
necro Thanks CCMDBIO...my lover we have to say good bye...i promise i will always watching from the sky...dispose at RM3.41 at 11.6.18...

For calculation of ex bonus issue price can use this calculator
12/06/2018 12:45
necro For all who still holding CCMDBIO, Please take care good of her...hehe
12/06/2018 12:46
Christine Chen Thank you, necro.
12/06/2018 17:14
marvin95 Why still haven’t get the bonus issue?
18/06/2018 10:08
ChipSaham Tomorrow will payout day
18/06/2018 17:07
ChipSaham If u hv 10000unit .then the bonus shares will get 4unit bonus shares for every 3shares


Total.new unit=10000+13333=23333
18/06/2018 17:10
Yu_and_Mee Is this counter will be impacted by monopoly in Pharma to hospital?
19/06/2018 18:59
Sebastian Sted Power https://youtu.be/RnOmGcCVnvA

Obviously we can guess which companies lo. Hahahaha
22/06/2018 17:08
man share hunting what happen to the dividend pay out..need to redeem.by re-invest ??.what is that ??
22/06/2018 17:28
man share hunting I got 900 shares which given me 43..what is means that ??
22/06/2018 17:28
marvin95 You may choose whether want cash or shares
24/06/2018 16:08
ZEPAN Major shareholders supports to cushion downside. Following the completion of
6sen final dividend (ex-date 13 June) and 4:3 bonus issue (14 June), CCMDBIO’s
prices slid 13.4% on profit taking from historical high of RM1.49 (21 Jun) to end at
RM1.29 yesterday. We remain positive on the stock as share prices continue to trend
above the long term uptrend, we see limited downside risks for CCMDBIO amid its
earnings resilience and institutional supports from major shareholders such as PNB
(46.9%) and EPF (7.3%).
We see an imminent bullish flag breakout, which bodes well for further advance
towards RM1.38 (23.6% FR) and RM1.49 before reaching our LT objective at RM1.55
(upper channel). Supports are located at RM1.25 (lower Bollinger band) and RM1.21
(LT support trendline). Cut loss at RM1.18.
10/07/2018 09:05
ZEPAN Recent retracement provides good opportunity to accumulate CCMDBIO in view
of its steady 7% FY17-20 EPS CAGR and decent FY18-20 3.1-3.5% DY,
supported by capacity and markets expansions, strong collaborations with
reputable partners and bullish sector outlook. We anticipate a bullish flag
breakout to spur prices towards RM1.38-1.55 levels in the mid to long term.
10/07/2018 11:33
ZEPAN Bought some yesterday. Anyone interested?
12/07/2018 07:42
ZEPAN Good performance, now more buyers, huhu
13/07/2018 17:06
Tete7893 i interested it . just wait 1.20-1.23
13/07/2018 23:00


414  333  575  613 

Top 10 Active Counters
 MYEG 1.24+0.12 
 IWCITY 0.81+0.065 
 NOVA 0.76+0.21 
 HSI-H4I 0.65-0.05 
 HSI-C3N 0.345+0.02 
 GKENT 1.47+0.06 
 MRCB 0.710.00 
 AAX 0.38+0.025 
 HSI-C3O 0.465+0.03 
 UCREST 0.405+0.03 
Partners & Brokers